Transgenic and/or gene-edited elite germplasm has high potential for commercialization. Our framework focuses on maximizing the chances to deliver a commercial product beyond the ideation stage.
The creation of a diverse pipeline that builds upon optimizing gene concepts is based on the most advanced scientific understanding of HLB resistance at UF and the use of advanced computation pathology approaches (AI) will help to mitigate risks and speed outputs.
The diverse genetic pipeline offers Florida growers options and reassurances that when resistance is lost, there are other candidate traits in the pipeline to combat HLB. Research on how to grow tolerant and susceptible refuges will minimize the probability of loss of citrus
resistance.
Human dimension work adds value to the grower in the form of better understanding a) growers’ criteria to advance a genetic concept from idea to product, b) barriers to adoption and factors that can derail the project, and c) the creation of educational materials and communications to increase consumer literacy regarding the value of new and improved citrus products.